GS vs MPLT · P/E 20, rev $37.56B vs $1.24B cap
Goldman Sachs Group Inc (GS) versus MapLight Therapeutics, Inc. Common Stock (MPLT) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Latest reported GS revenue for 2026-06-30 was $37.56B. Net income was $12.26B. GS currently screens at market cap $324.25B and trailing P/E 20.1.
MPLT does not have a complete income-statement cache yet.
GS currently screens at market cap $324.25B and trailing P/E 20.1. MPLT currently screens at market cap $1.24B.
Not investment advice. Open the GS and MPLT stock pages for the full models.
Not investment advice.